tradingkey.logo
tradingkey.logo
Search

Premarket Movers | Zoom Rallies over 5%; USA Rare Earth Rises 4%; SBET Gains over 3%; Novo Jumps over 2%; Palantir Falls Nearly 1%

TigerAug 22, 2025 8:55 AM
facebooktwitterlinkedin
View all comments0

Shares of Novo Nordisk rose over 2% in premarket trading. Novo Nordisk said on Monday that it was launching a new offer for self-paying type 2 diabetes patients in the U.S. to access Ozempic for $499 per month.

Palantir stock fell 0.7% in premarket trading. According to Tyler Radke, a senior Citigroup equity analyst, Palantir’s lofty valuations are difficult to justify despite its “outstanding Q2 results.”

The stock has declined 15% over the past week, after Andrew Left’s Citron Research revealed a short position in the company.

Yet, Radke warns that the company’s valuation is still too rich, “this stock, even despite its slide, is still trading at around 70 times forward revenue,” he notes, adding that it was on the high end of the broader market’s valuation range, while speaking on CNBC’s ‘Squawk Box’ on Thursday.

Zoom raised its annual revenue and profit forecasts on Thursday, banking on hybrid work trends and the integration of artificial intelligence technology into its products, sending its shares up over 5% in premarket trading.

Crypto shares gained in premarket trading. SharpLink Gaming, BitMine, Upexi, DeFi Devi up over 3%; Circle up 2%.

Rare earth shares jumped in premarket trading. USA Rare Earth up about 4%; The Metals up 2%.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.